Pearl River Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,948
Closed -$786K 658
2023
Q3
$786K Sell
3,948
-1,321
-25% -$312K 0.12% 254
2023
Q2
$1.5M Buy
5,269
+100
+2% +$27.8K 0.24% 135
2023
Q1
$1.12M Sell
5,169
-878
-15% -$171K 0.18% 181
2022
Q4
$1.24M Sell
6,047
-180
-3% -$45.5K 0.21% 156
2022
Q3
$1.73M Buy
6,227
+3,789
+155% +$964K 0.32% 88
2022
Q2
$466K Sell
2,438
-1,552
-39% -$274K 0.11% 273
2022
Q1
$827K Buy
3,990
+2,207
+124% +$364K 0.23% 138
2021
Q4
$318K Sell
1,783
-298
-14% -$58.8K 0.09% 297
2021
Q3
$428K Buy
+2,081
New +$409K 0.12% 248

Other funds holding SWAV

Pearl River Capital's SWAV Position: Q4 2023 in Review

Pearl River Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 3,948 shares — an estimated $786K sold.

Pearl River Capital first reported a position in SWAV in Q3 2021 and held it in 9 quarters. The position peaked at $1.73M in Q3 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Pearl River Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Pearl River Capital sold 3,948 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $786K.
  • Pearl River Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Pearl River Capital's Shockwave Medical, Inc. Common Stock position peaked at $1.73M in Q3 2022.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Pearl River Capital's 13F filing for Q4 2023, filed 13 Feb 2024.